Dr. Vanderah is a Professor and the Head of Pharmacology, College of Medicine, at the University of Arizona. He has worked in the area of Neuropharmacology for over 20 years, which has resulted in 170 peer-reviewed publications and continual NIH funding since his appointment, and he is the author of three Neuroscience Text Books. Dr. Vanderah completed his PhD in Pharmacology and Toxicology at the UofA. He did his Post-doctoral Fellowship at the University of Colorado where he learned electrophysiology, studying the effects of alcohol on ion channels/G-proteins. He worked for 4.5 years at a small pharmaceutical company, Ferring Inc., where he developed several novel drugs that are commercially available.
Dr. Vanderah is a Professor and the Head of Pharmacology, College of Medicine, at the University of Arizona. He has worked in the area of Neuropharmacology for over 20 years, which has resulted in 170 peer-reviewed publications and continual NIH funding since his appointment, and he is the author of three Neuroscience Text Books. Dr. Vanderah completed his PhD in Pharmacology and Toxicology at the UofA. He did his Post-doctoral Fellowship at the University of Colorado where he learned electrophysiology, studying the effects of alcohol on ion channels/G-proteins. He worked for 4.5 years at a small pharmaceutical company, Ferring Inc., where he developed several novel drugs that are commercially available.